EKZRF (Eckert & Ziegler SE) EPS without NRI: $0.92 (TTM As of Mar. 2026)


EKZRF Eckert & Ziegler SE EKZRF
77 GF Score
Price $18.00
GF Value $19.67
Valuation Fairly Valued
View Full Analysis

What is Eckert & Ziegler SE EPS without NRI?

Eckert & Ziegler SE EKZRF 77 EPS without NRI is $0.92 as of Mar. 2026. GuruFocus rates EKZRF with a GF Score™ of 77/100 and a GF Value™ of $19.67 (Fairly Valued). Among 662 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks better than 57.25% on this metric.

Eckert & Ziegler SE's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.20. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.92.

During the past 12 months, Eckert & Ziegler SE's average earnings per share (NRI) Growth Rate was 5.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 13.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 15.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Eckert & Ziegler SE's EPS without NRI or its related term are showing as below:

EKZRF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -17.6   Med: 11.3   Max: 70.6
Current: 13.5

During the past 13 years, Eckert & Ziegler SE's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 70.60% per year. The lowest was -17.60% per year. And the median was 11.30% per year.

EKZRF's 3-Year EPS without NRI Growth Rate is ranked better than
57.25% of 662 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs EKZRF: 13.50

Eckert & Ziegler SE's EPS (Diluted) for the three months ended in Mar. 2026 was $0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.92.

Eckert & Ziegler SE's EPS (Basic) for the three months ended in Mar. 2026 was $0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.93.


Eckert & Ziegler SE  (OTCPK:EKZRF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Eckert & Ziegler SE EPS without NRI Related Terms


Eckert & Ziegler SE EPS without NRI Historical Data

* Premium members only.

The historical data trend for Eckert & Ziegler SE's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eckert & Ziegler SE EPS without NRI Chart

Eckert & Ziegler SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.57 0.55 0.77 0.92

Eckert & Ziegler SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.22 0.16 0.34 0.20

EKZRF vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Eckert & Ziegler SE's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's PE Ratio without NRI falls into.


EKZRF
77GF Score
Eckert & Ziegler SE EKZRF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eckert & Ziegler SE EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.92 mean?
Eckert & Ziegler SE (EKZRF) has a EPS without NRI of $0.92 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Eckert & Ziegler SE and its competitors. According to the industry distribution chart, Eckert & Ziegler SE ranks #283 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 42.7%.
Is Eckert & Ziegler SE's EPS without NRI too high?
Eckert & Ziegler SE's current EPS without NRI is $0.92. The Medical Devices & Instruments industry median EPS without NRI is 8.15. Eckert & Ziegler SE's value of $0.92 is 88.7% below this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #283 out of 662 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #283 out of 662 companies for EPS without NRI. This puts Eckert & Ziegler SE in the upper half of its industry. The industry median EPS without NRI is 8.15. Eckert & Ziegler SE's value of $0.92 is 88.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current EPS without NRI of $0.92 is 88.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current EPS without NRI is $0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (EKZRF) is currently considered Fairly Valued. The stock's GF Value™ is $19.67, compared to a current price of $18.00 — trading 8.5% below its estimated fair value. The current EPS without NRI is $0.92 and 88.7% below the Medical Devices & Instruments industry median of 8.15. Eckert & Ziegler SE's overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Eckert & Ziegler SE (EKZRF), the current EPS without NRI is $0.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eckert & Ziegler SE (EKZRF) Overvalued in 2026?

Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued. The current stock price of $18.00 is trading 8.5% below its estimated GF Value™ of $19.67. GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.

Key valuation signals for EKZRF:

  • EPS without NRI: $0.92
  • GF Value™: $19.67 vs. price of $18.00 (8.5% below fair value)
  • GF Score™: 77/100
  • Industry Position: 88.7% below the Medical Devices & Instruments median (#283 of 662)

No single metric tells the full story. See the EKZRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eckert & Ziegler SE Business Description

Address Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
77GF Score

Get the complete analysis for EKZRF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.00
Price
$19.67
GF Value